Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Mendelian randomization of blood lipids for coronary heart disease

Holmes, Michael V. ; Asselbergs, Folkert W. ; Palmer, Tom M. ; Drenos, Fotios ; Lanktree, Matthew B. ; Nelson, Christopher P. ; Dale, Caroline E. ; Padmanabhan, Sandosh ; Finan, Chris and Swerdlow, Daniel I. , et al. (2015) In European Heart Journal 36(9). p.539-539
Abstract
Aims To investigate the causal role of high-density lipoprotein cholesterol (HDL-C) and triglycerides in coronary heart disease (CHD) using multiple instrumental variables for Mendelian randomization. Methods and results We developed weighted allele scores based on single nucleotide polymorphisms (SNPs) with established associations with HDL-C, triglycerides, and low-density lipoprotein cholesterol (LDL-C). For each trait, we constructed two scores. The first was unrestricted, including all independent SNPs associated with the lipid trait identified from a priormeta-analysis (threshold P < 2 x 10(-6)); and the second a restricted score, filtered to remove any SNPs also associated with either of the other two lipid traits at P <=... (More)
Aims To investigate the causal role of high-density lipoprotein cholesterol (HDL-C) and triglycerides in coronary heart disease (CHD) using multiple instrumental variables for Mendelian randomization. Methods and results We developed weighted allele scores based on single nucleotide polymorphisms (SNPs) with established associations with HDL-C, triglycerides, and low-density lipoprotein cholesterol (LDL-C). For each trait, we constructed two scores. The first was unrestricted, including all independent SNPs associated with the lipid trait identified from a priormeta-analysis (threshold P < 2 x 10(-6)); and the second a restricted score, filtered to remove any SNPs also associated with either of the other two lipid traits at P <= 0.01. Mendelian randomization meta-analyses were conducted in 17 studies including 62,199 participants and 12,099 CHD events. Both the unrestricted and restricted allele scores for LDL-C (42 and 19 SNPs, respectively) associated with CHD. For HDL-C, the unrestrictedallele score (48SNPs) was associated with CHD(OR: 0.53; 95% CI: 0.40, 0.70), per 1 mmol/L higher HDL-C, but neither the restricted allele score (19 SNPs; OR: 0.91; 95% CI: 0.42, 1.98) nor the unrestricted HDL-C allele score adjusted for triglycerides, LDL-C, or statin use (OR: 0.81; 95% CI: 0.44, 1.46) showed a robust association. For triglycerides, the unrestricted allele score (67 SNPs) and the restricted allele score (27 SNPs) were both associated with CHD (OR: 1.62; 95% CI: 1.24, 2.11 and 1.61; 95% CI: 1.00, 2.59, respectively) per 1-log unit increment. However, the unrestricted triglyceride score adjusted for HDL-C, LDL-C, and statin use gave an OR for CHD of 1.01 (95% CI: 0.59, 1.75). Conclusion The genetic findings support a causal effect of triglycerides on CHD risk, but a causal role for HDL-C, though possible, remains less certain. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Lipids, Heart disease, Mendelian randomization, Aetiology, Epidemiology
in
European Heart Journal
volume
36
issue
9
pages
539 - 539
publisher
Oxford University Press
external identifiers
  • wos:000351591800007
  • scopus:84924420487
  • pmid:24474739
ISSN
1522-9645
DOI
10.1093/eurheartj/eht571
language
English
LU publication?
yes
id
0a984a07-185b-496a-b980-e64a0bc4a3e2 (old id 5281446)
date added to LUP
2016-04-01 14:17:33
date last changed
2024-01-10 00:29:30
@article{0a984a07-185b-496a-b980-e64a0bc4a3e2,
  abstract     = {{Aims To investigate the causal role of high-density lipoprotein cholesterol (HDL-C) and triglycerides in coronary heart disease (CHD) using multiple instrumental variables for Mendelian randomization. Methods and results We developed weighted allele scores based on single nucleotide polymorphisms (SNPs) with established associations with HDL-C, triglycerides, and low-density lipoprotein cholesterol (LDL-C). For each trait, we constructed two scores. The first was unrestricted, including all independent SNPs associated with the lipid trait identified from a priormeta-analysis (threshold P &lt; 2 x 10(-6)); and the second a restricted score, filtered to remove any SNPs also associated with either of the other two lipid traits at P &lt;= 0.01. Mendelian randomization meta-analyses were conducted in 17 studies including 62,199 participants and 12,099 CHD events. Both the unrestricted and restricted allele scores for LDL-C (42 and 19 SNPs, respectively) associated with CHD. For HDL-C, the unrestrictedallele score (48SNPs) was associated with CHD(OR: 0.53; 95% CI: 0.40, 0.70), per 1 mmol/L higher HDL-C, but neither the restricted allele score (19 SNPs; OR: 0.91; 95% CI: 0.42, 1.98) nor the unrestricted HDL-C allele score adjusted for triglycerides, LDL-C, or statin use (OR: 0.81; 95% CI: 0.44, 1.46) showed a robust association. For triglycerides, the unrestricted allele score (67 SNPs) and the restricted allele score (27 SNPs) were both associated with CHD (OR: 1.62; 95% CI: 1.24, 2.11 and 1.61; 95% CI: 1.00, 2.59, respectively) per 1-log unit increment. However, the unrestricted triglyceride score adjusted for HDL-C, LDL-C, and statin use gave an OR for CHD of 1.01 (95% CI: 0.59, 1.75). Conclusion The genetic findings support a causal effect of triglycerides on CHD risk, but a causal role for HDL-C, though possible, remains less certain.}},
  author       = {{Holmes, Michael V. and Asselbergs, Folkert W. and Palmer, Tom M. and Drenos, Fotios and Lanktree, Matthew B. and Nelson, Christopher P. and Dale, Caroline E. and Padmanabhan, Sandosh and Finan, Chris and Swerdlow, Daniel I. and Tragante, Vinicius and van Iperen, Erik P. A. and Sivapalaratnam, Suthesh and Shah, Sonia and Elbers, Clara C. and Shah, Tina and Engmann, Jorgen and Giambartolomei, Claudia and White, Jon and Zabaneh, Delilah and Sofat, Reecha and McLachlan, Stela and Doevendans, Pieter A. and Balmforth, Anthony J. and Hall, Alistair S. and North, Kari E. and Almoguera, Berta and Hoogeveen, Ron C. and Cushman, Mary and Fornage, Myriam and Patel, Sanjay R. and Redline, Susan and Siscovick, David S. and Tsai, Michael Y. and Karczewski, Konrad J. and Hofker, Marten H. and Verschuren, W. Monique and Bots, Michiel L. and van der Schouw, Yvonne T. and Melander, Olle and Dominiczak, Anna F. and Morris, Richard and Ben-Shlomo, Yoav and Price, Jackie and Kumari, Meena and Baumert, Jens and Peters, Annette and Thorand, Barbara and Koenig, Wolfgang and Gaunt, Tom R. and Humphries, Steve E. and Clarke, Robert and Watkins, Hugh and Farrall, Martin and Wilson, James G. and Rich, Stephen S. and de Bakker, Paul I. W. and Lange, Leslie A. and Smith, George Davey and Reiner, Alex P. and Talmud, Philippa J. and Kivimaeki, Mika and Lawlor, Debbie A. and Dudbridge, Frank and Samani, Nilesh J. and Keating, Brendan J. and Hingorani, Aroon D. and Casas, Juan P.}},
  issn         = {{1522-9645}},
  keywords     = {{Lipids; Heart disease; Mendelian randomization; Aetiology; Epidemiology}},
  language     = {{eng}},
  number       = {{9}},
  pages        = {{539--539}},
  publisher    = {{Oxford University Press}},
  series       = {{European Heart Journal}},
  title        = {{Mendelian randomization of blood lipids for coronary heart disease}},
  url          = {{https://lup.lub.lu.se/search/files/3893699/8171308}},
  doi          = {{10.1093/eurheartj/eht571}},
  volume       = {{36}},
  year         = {{2015}},
}